Newer Therapeutic Options for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Author： Kuitwaard Krista   van Doorn Pieter A.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.69, Iss.8, 2009-06, pp. : 987-1001

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

By Hughes R.A.C.  

Drugs, Vol. 63, Iss. 3, 2003-01 ,pp. : 275-287

Adis International

Access to resources Recommend Favorite

A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy

By Léger Jean-Marc  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 569-582

Informa Healthcare

Access to resources Recommend Favorite

Oxaliplatin: Acute inflammatory demyelinating polyradiculoneuropathy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. : 35-35

Adis International

Access to resources Recommend Favorite

Chronic Inflammatory Demyelinating Polyneuropathy Possibly Associated with Tacrolimus

By Haviv Y.S.   Friedlaender M.   Dranitzki-Elhallel M.  

Clinical Drug Investigation, Vol. 18, Iss. 2, 1999-08 ,pp. : 169-172

Adis International

Access to resources Recommend Favorite

Traditional and Newer Therapeutic Options for Psoriatic Arthritis: An Evidence-Based Review

By Gladman Dafna D.  

Drugs, Vol. 65, Iss. 9, 2005-01 ,pp. : 1223-1238

Adis International

Access to resources Recommend Favorite